Cormorant Asset Management, LP, 10% Owner at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 750,000 shares at $19.00 ($14.3M) on 2024-02-02, disclosed to the SEC on 2024-02-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| DRUG | BUY | 2024-11-06 | $8.0M | — | Filing → |
| EYPT | BUY | 2024-05-08 | $20.2M | — | Filing → |
| EYPT | BUY | 2024-01-11 | $17.1M | — | Filing → |